过去一年中添加的文章,按日期排序
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older
S Yagishita, Y Yamanaka, T Kurata… - Clinical Pharmacology … - Wiley Online Library
3 天前 - … In 99 patients aged ≥75 years, PK was determined by liquid chromatography–mass
spectrometry on pretreatment samples. Performance status (PS), geriatric assessment (GA)…
spectrometry on pretreatment samples. Performance status (PS), geriatric assessment (GA)…
БЮЛЛЕТЕНЬ СИБИРСКОЙ МЕДИЦИНЫ
ЕС ГЕРШТЕЙН, ОВ КОВАЛЕВА… - БЮЛЛЕТЕНЬ …, 2024 - elibrary.ru
7 天前 - … adenocarcinoma, 29 - as squamous-cell carcinoma, 11 - as small-cell LC (SCLC),
and 2 - as large-cell lung carcinoma. The pre-treatment KISS1 level in the blood serum was …
and 2 - as large-cell lung carcinoma. The pre-treatment KISS1 level in the blood serum was …
… of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer
A Tamiya, M Osuga, D Harada, S Isa, Y Taniguchi… - papers.ssrn.com
8 天前 - … observational study involved chemotherapy-naive patients with advanced non-small
cell lung cancer receiving osimertinib. Mutations in cancer-associated genes, detected via …
cell lung cancer receiving osimertinib. Mutations in cancer-associated genes, detected via …
Early Noninvasive Tracking of Response to Targeted Therapy in Non-Small Cell Lung Cancer
H Husain, K Lu, B Woodward, R Singhrao, M Javey… - 2024 - researchsquare.com
10 天前 - … samples of 25 patients with advanced nonsmall cell lung cancer and observed …
tumor DNA on therapy. We evaluated pre-treatment and post-treatment specimens from patients …
tumor DNA on therapy. We evaluated pre-treatment and post-treatment specimens from patients …
[HTML][HTML] High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)
MK Moutafi, KM Bates, TN Aung, RG Milian… - … of Cancer, 2024 - ncbi.nlm.nih.gov
10 天前 - … We analyzed retrospectively collected baseline/pretreatment FFPE tumor specimens
represented in four tissue microarrays (TMA) format from 56 patients with NSCLC treated …
represented in four tissue microarrays (TMA) format from 56 patients with NSCLC treated …
Prognostic Value of Body Composition in Therapy-Naive Patients with Non-Small Cell Lung Cancer
T KIRATLI YOLCU, S KESİM… - UHOD-Uluslararasi …, 2024 - avesis.marmara.edu.tr
11 天前 - … cell lung cancer (NSCLC) patients undergoing different therapy regimens. Eighty
three patients … Pre-treatment multi-slice and single-slice computed tomography images of PET/…
three patients … Pre-treatment multi-slice and single-slice computed tomography images of PET/…
Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer
T Hasegawa, T Okuyama, T Uemura, Y Matsuda… - … Care in Cancer, 2024 - Springer
11 天前 - … patients with pretreated non-small cell lung cancer from four study sites. Patients
and their oncologists were asked whether they perceived the disclosure of cancer incurability. …
and their oncologists were asked whether they perceived the disclosure of cancer incurability. …
Differences in systemic immune parameters in individuals with lung cancer according to race
MS von Itzstein, J Liu, H Mu-Mosley, FJ Fattah, JY Park… - bioRxiv, 2024 - biorxiv.org
11 天前 - … Enrolled individuals underwent collection of clinical data and collection of pretreatment
… patients with lung cancer. Although Black patients tended to have earlier-stage cancer …
… patients with lung cancer. Although Black patients tended to have earlier-stage cancer …
[PDF][PDF] Does Autoimmune Response Against Surfactant Protein Cause Interstitial Lung Disease?
S Watanabe, T Kikuchi - … Journal of Respiratory and Critical Care …, 2024 - atsjournals.org
14 天前 - … -cell antigens shared between skin and tumors (2). They showed that non-small cell
lung cancer (NSCLC) patients with T cells … in ICI-ILD patients in both pre-treatment and post-…
lung cancer (NSCLC) patients with T cells … in ICI-ILD patients in both pre-treatment and post-…
Sacituzumab govitecan (SG) vs docetaxel (doc) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) previously treated with platinum (PT)-based …
LG Paz-Ares, O Juan-Vidal, GS Mountzios, E Felip… - 2024 - ascopubs.org
15 天前 - … SG, a Trop-2-directed antibody drug conjugate, showed durable response and
tolerable safety in pretreated mNSCLC. We report results from the phase 3, randomized, open-…
tolerable safety in pretreated mNSCLC. We report results from the phase 3, randomized, open-…